As the following maxim states, “do something that not just anyone is able to do," Cyndea Pharma aims to focus its efforts on the development and manufacturing of generic drugs associated with a distinctive complexity, either by their difficulty to develop pharmaceutically, or their handling incompatibility with other types of high activity products, or furthermore for their technical difficulty or the complex technological installations required for their manufacturing (proper facilities for the handling of hormones).
Cyndea Pharma invests in its own products for subsequent licensing to commercializing companies, but also offers its expertise in development and manufacturing of high activity generic medicines to companies that do not have the “know-how” or industrial capabilities needed for handling such products, as a way to outsource drug development and manufacturing of high activity medicines with the best guarantees in terms of quality, time and cost.

• “Licensing-out”of high activity generic medicines.
• "Contract Manufacturing”high activity medicines. 
• “Contract Development”of high activity medicines:  


• Galenic formulation of oral solids
• Analytical development
• Manufacturing and packaging of batches for clinical trials
• Stability studies
• Documentation dossier for the pharmaceutical registry